×
Net sales rose 8.5% year over year to $383 million, slightly below the consensus estimate of roughly $389 million. GAAP (Generally Accepted Accounting Principles) earnings per share came in at a loss of $3.40, well below the roughly breakeven analyst estimate, driven by a $221 million non-cash asset impairment.
Huntsman reported third quarter 2026 revenue of $1,717 million, up 18% year over year and above the consensus estimate of about $1,613 million. Adjusted diluted earnings per share (EPS) came in at $0.04, below the roughly $0.06-to-$0.07 analyst consensus, while the GAAP (Generally Accepted Accounting Principles) diluted loss narrowed to $0.10 per share from $0.14 a year earlier.
Celanese reported third quarter 2026 adjusted earnings per share (EPS) of $1.65, above the consensus estimate of roughly $1.55. Net sales reached $2,556 million, up 6% year over year, though slightly below the consensus estimate of about $2.62 billion.
DOW (Dow Inc.) is a cyclical materials-science and chemicals producer whose recent results have been lifted by cost cuts and improving polyethylene pricing, while MMM (3M Company) is a diversified industrial and technology company gaining traction from AI data center and optical connectivity demand. 3M raised its full-year earnings guidance and expanded partnerships with major hyperscalers, whereas Dow is executing a multi-year cost-restructuring program amid a still-soft commodities cycle.
Self-help is the central story. Dow's "Transform to Outperform" program targets at least $2 billion in near-term EBITDA (earnings before interest, taxes, depreciation, and amortization) improvement, layered on top of a $1 billion cost-savings plan expected to be completed by the end of 2026. Capacity reshuffling favors low-cost regions. With roughly 15%–20% of European ethylene capacity being rationalized, Dow's cost-advantaged U.S. Gulf Coast and Canadian assets are positioned to gain share as higher-cost production exits.
The central target of $38 is the arithmetic mean of the three most recent analyst price targets that sit above the current share price: $40 (J.P. Morgan), $39 (Morgan Stanley), and $35 (Wells Fargo). The latest verified price for DOW is about $33.62, meaning the stock would need to rise roughly 13% to reach the $38 central target.
Dow Inc. (DOW) shares climbed roughly 23% over the last 30 days, rising from a closing price near $27.54 on September 30, 2026 to about $33.90 in late October 2026. The rally accelerated after Dow's third-quarter 2026 results, which beat Wall Street expectations and reinforced the company's self-help and pricing story.
Olin reported third quarter 2026 sales of $1.75 billion and net income of $14.4 million, or $0.13 per diluted share, down from $42.8 million in the prior-year quarter. Results fell short of consensus: adjusted EPS of roughly $0.13–$0.14 came in below estimates near $0.15–$0.16, and revenue missed the $1.83–$1.84 billion consensus.
Methanex reported third quarter 2026 net income attributable to shareholders of $265 million ($3.42 per diluted share), up from $198 million ($2.45 per share) in the second quarter of 2026. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) was $543 million , down from $577 million in the prior quarter as the average realized methanol price eased to $510 per tonne from $529 per tonne.
Braskem's ADRs have declined roughly 39% over the past 30 days, falling from about $1.54 to around $0.94 per share. The sell-off extends a longer slide: BAK is down roughly 62% over the last three months from about $2.46 per share.
BAK plunged -44.12% during the regular session to about $0.95, after closing the prior session at $1.70. Primary catalyst: Braskem filed an extrajudicial (out-of-court) reorganization for roughly $10.9 billion of debt in a São Paulo court.
Dow reported third-quarter 2026 net sales of $11.27 billion , up 13% year over year, with growth in every operating segment. Operating (adjusted) earnings per share came in at $0.71 , beating the consensus estimate of $0.64 .
Both DOW and LYB have benefited from higher petrochemical prices following Middle East supply disruptions, but they are executing very different strategies. DOW delivered a strong third quarter, beating earnings estimates on higher polyethylene prices and aggressive cost-cutting, and guided above expectations for the fourth quarter.
Braskem S.A. (BAK) has fallen about 22% over the past 30 days, from a $2.67 close on July 14, 2026, to the latest available price near $2.08 in mid-August. The decline reflects unresolved debt-restructuring negotiations, creditor rejection of the company's initial proposal, and a June court-protection filing that led S&P Global Ratings to cut Braskem to 'D'.
BAK shares cratered 11.93% in after-hours trading, plunging from a previous close of $3.73 to $3.285 . The primary catalyst was the closing of the Novonor stake sale and the unveiling of a new controlling shareholder structure involving IG4 and Petrobras.
HUN shares plunged 16.65% to $13.25 as of mid-afternoon trading on June 16, 2026, from a prior close of $15.89. The primary catalyst is the announcement of an all-stock merger of equals with Olin Corporation (OLN), triggering textbook merger arbitrage price convergence.
ASPI stock rose approximately +15% over the past 30 days, driven by a key memorandum of understanding (MOU) for high-assay low-enriched uranium (HALEU) supply through its subsidiary Quantum Leap Energy. Over the past quarter, the stock gained around +15%, reflecting volatility but supported by progress in isotope production milestones and nuclear energy partnerships.
Shares of DOW are plunging approximately 12% in Friday's session, declining from a prior close of $39.92 to around $35.13, as the Iran conflict-driven petrochemical pricing advantage that powered the stock's 70%+ year-to-date rally rapidly unravels. The primary catalyst is the accelerating unwind of the geopolitical war premium: advancing U.S.-Iran diplomatic talks threaten to reopen the Strait of Hormuz, which would collapse the artificially elevated U.S.-to-Asia petrochemical pricing arbitrage that has been a direct earnings tailwind for Dow Inc.
DOW shares are down approximately 11% in Wednesday's session, sharply underperforming a broadly rallying equity market. The immediate catalyst is a dramatic collapse in crude oil prices—Brent fell over 14% to around $93.8/barrel and WTI dropped nearly 16% to approximately $95/barrel—triggered by the US-Iran two-week ceasefire announced the evening of April 7.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​